Dalila C Pinto, PhD
img_Dalila C Pinto
ASSISTANT PROFESSOR | Psychiatry
ASSISTANT PROFESSOR | Genetics and Genomic Sciences
Research Topics
Autism, Bioinformatics, Chromatin, Computational Biology, Epilepsy, Gene Discovery, Gene Expressions, Gene Regulation, Genetics, Genomics, Mental Retardation, Microarray, Transcription Factors
Multi-Disciplinary Training Area
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS], Neuroscience [NEU]
For more information see the Pinto Lab website.

MSc, MSc, University of Porto

PhD, University of Utrecht

Postdoctoral, Hospital for Sick Children Toronto

Publications

Selected Publications

Correction: High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy (Acta Neuropathologica Communications, (2022), 10, 1, (149), 10.1186/s40478-022-01453-1). Balagopal Pai, Jessica Tome‑Garcia, Wan Sze Cheng, German Nudelman, Kristin G. Beaumont, Saadi Ghatan, Fedor Panov, Elodia Caballero, Kwadwo Sarpong, Lara Marcuse, Jiyeoun Yoo, Yan Jiang, Anne Schaefer, Schahram Akbarian, Robert Sebra, Dalila Pinto, Elena Zaslavsky, Nadejda M. Tsankova. Acta neuropathologica communications

High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy. Balagopal Pai, Jessica Tome-Garcia, Wan Sze Cheng, German Nudelman, Kristin G. Beaumont, Saadi Ghatan, Fedor Panov, Elodia Caballero, Kwadwo Sarpong, Lara Marcuse, Jiyeoun Yoo, Yan Jiang, Anne Schaefer, Schahram Akbarian, Robert Sebra, Dalila Pinto, Elena Zaslavsky, Nadejda M. Tsankova. Acta neuropathologica communications

Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Vassily Trubetskoy, Antonio F. Pardiñas, Ting Qi, Georgia Panagiotaropoulou, Swapnil Awasthi, Tim B. Bigdeli, Julien Bryois, Chia Yen Chen, Charlotte A. Dennison, Lynsey S. Hall, Max Lam, Kyoko Watanabe, Oleksandr Frei, Tian Ge, Janet C. Harwood, Frank Koopmans, Sigurdur Magnusson, Alexander L. Richards, Julia Sidorenko, Yang Wu, Jian Zeng, Jakob Grove, Minsoo Kim, Zhiqiang Li, Georgios Voloudakis, Wen Zhang, Mark Adams, Ingrid Agartz, Elizabeth G. Atkinson, Esben Agerbo, Mariam Al Eissa, Margot Albus, Madeline Alexander, Behrooz Z. Alizadeh, Kenneth L. Davis, Vahram Haroutunian, Dolores Malaspina, Abraham Reichenberg, Larry J. Siever, Jeremy M. Silverman, Schahram Akbarian, Harm van Bakel, Michael Breen, Alex Charney, Kiran Girdhar, Gabriel Hoffman, Donghoon Lee, Dalila Pinto, Joseph D. Buxbaum, Panos Roussos. Nature

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Pinto did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.